Ethel C Feleder

Title: Ethel C Feleder: Innovator in Osmotic Device Technology

Introduction

Ethel C Feleder is a notable inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of osmotic devices, holding three patents that showcase her innovative spirit and technical expertise. Her work focuses on the development of drug delivery systems that enhance the efficacy and control of medication release.

Latest Patents

Feleder's latest patents include an osmotic device containing amantadine and an osmotic salt. This device features a unitary core that comprises a salt of amantadine and an osmotic salt, which share a common ion. The release rate of amantadine is characterized by a sigmoidal release profile. The device is designed with a semipermeable membrane that has controlled porosity, allowing for a predetermined drug release profile. Additionally, the osmotic device can include one or more additional drugs in the core or the drug-containing coat.

Another significant patent involves an osmotic device containing a venlafaxine salt and a salt with a common ion. This device includes a single core that modifies the release profile of the active drug from a first-order to a zero-order, pseudo-zero-order, or sigmoidal release profile. By increasing the amount of sodium chloride in the core, the device achieves a delayed and controlled release profile.

Career Highlights

Throughout her career, Ethel C Feleder has worked with companies such as Osmotica Kereskedelmi És Szolgáltató Kft and Osmotica Kereskedelmi És Szolgáltató Kft. Her experience in these organizations has contributed to her expertise in osmotic device technology and drug delivery systems.

Collaborations

Feleder has collaborated with notable individuals in her field, including Joaquina Faour and Glenn A Meyer. These partnerships have likely enriched her research and development efforts, leading to innovative solutions in drug delivery.

Conclusion

Ethel C Feleder is a pioneering inventor whose work in osmotic devices has the potential to transform drug delivery systems. Her patents reflect her commitment to improving medication efficacy and control, making her a significant figure in the field of pharmaceutical innovations.